INVIVO THERAPEUTICS HLDGS CO's ticker is NVIV and the CUSIP is 46186M209. A total of 63 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q2 2016. The put-call ratio across all filers is 0.32 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $0 | -100.0% | 500 | 0.0% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | -50.0% | 500 | -8.6% | 0.00% | – |
| Q1 2017 | $2,000 | -98.6% | 547 | -98.3% | 0.00% | – |
| Q4 2016 | $138,000 | +557.1% | 32,906 | +947.0% | 0.00% | – |
| Q3 2016 | $21,000 | +162.5% | 3,143 | +127.9% | 0.00% | – |
| Q2 2016 | $8,000 | -95.7% | 1,379 | -94.9% | 0.00% | – |
| Q1 2016 | $188,000 | +4600.0% | 26,864 | +5251.4% | 0.00% | – |
| Q4 2015 | $4,000 | -98.8% | 502 | -98.7% | 0.00% | – |
| Q3 2015 | $327,000 | +5350.0% | 38,029 | +10922.9% | 0.00% | – |
| Q2 2015 | $6,000 | – | 345 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|